Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life
<p>Abstract</p> <p>Purpose</p> <p>To assess treatment toxicity and patients' survival/quality of life (QoL) after volumetric modulated arc therapy (VMAT) with simultaneous in-field boost (SIB) for cancer patients with 1 - 4 brain metastases (BM) treated with or wit...
Main Authors: | Malek Karim, Laouiti Mohamed, Caparrotti Francesca, Weber Damien C |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/6/1/79 |
Similar Items
-
Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost
by: Cole Steber, MD, et al.
Published: (2021-01-01) -
Simultaneous Integrated Boost by Volumetric Modulated Arc Therapy (VMAT) with Concurrent Mitomycin and Capecitabine in Anal Canal Carcinoma
by: Engy Aboelnaga, et al.
Published: (2019-07-01) -
The patient-reported outcome measures in oropharyngeal, laryngeal and hypopharyngeal cancer patients treated with Volumetric Modulated Arc based simultaneous integrated boost radiotherapy
by: Thiraviyam Elumalai, et al.
Published: (2021-06-01) -
Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy
by: Vanetti Eugenio, et al.
Published: (2009-07-01) -
Dosimetric Comparison between High Dose Rate Brachytherapy Boost and Volumetric Arc Therapy Boost in Locally Advanced Cancer Cervix
by: Hanady Hegazy, et al.
Published: (2021-04-01)